Having seen over $200 billion in collective AUM and net worth flow through our Jets & Capital events, I can confirm that family offices are shifting from "wait-and-see" to active deployment in quantum infrastructure. The market remains exceptionally well-funded by private capital, with 2026-2027 generally viewed as the inflection point for commercial-grade fault tolerance. Trade wars and tariffs actually strengthen domestic leaders like IonQ (IONQ), as Western governments prioritize secure, sovereign supply chains over Chinese components. For stability, I like Honeywell (HON) because they combine massive industrial cash flow with a world-class trapped-ion roadmap that is less sensitive to global trade volatility. For diversified exposure, the Defiance Quantum ETF (QTUM) is the premier way to play the hardware race without the risk of a single-firm failure. I also watch D-Wave (QBTS) closely, as their focus on optimization problems aligns with the logistics and supply chain deals we see discussed by CIOs in our network. New investors should treat quantum like a venture capital allocation, vetting the technical leadership as strictly as we vet the attendees for our hangar events. Only deploy capital you can afford to lock away for five years, focusing on firms that have secured long-term government or enterprise contracts.
As CEO of Lifebit, I leverage high-performance computing (HPC) to transform global healthcare, making me a first-hand observer of the "raw computational power" quantum brings to drug discovery. The market remains well-funded as we hit a "perfect storm" of regulatory support for AI-driven research, with commercial applications for complex genomic modeling on track for 2026. Tariff wars and ties to the Chinese economy create significant "delivery risk" for hardware providers, mirroring the regulatory bottlenecks I see in cross-border health data. Investors should favor companies that utilize "infrastructure-agnostic" models to bypass these geopolitical supply chain disruptions and avoid vendor lock-in. I like **IonQ** for its trapped-ion technology suited for molecular analysis and **NVIDIA (NVDA)** for its cuQuantum platform, which currently acts as the "picks and shovels" for our industry. For ETFs, the **Defiance Quantum ETF (QTUM)** is a standout because it includes the specialized HPC and machine learning leaders essential for large-scale biomedical research. My advice is to target companies that bridge the "skills gap" by offering low-code or "all-in-one" solutions that democratize access to advanced computing. Look for firms that integrate seamlessly with secure data ecosystems, such as Trusted Research Environments, to ensure their technology is actually usable by global health agencies and pharmaceutical organizations.
I run an independent advisory firm for entrepreneurs earning $400K+ and I'm in the weeds every month translating volatile macro headlines into portfolio decisions (March/April 2025 tariffs, risk-off flows into cash/gold, and sharp equity drawdowns). Quantum is still well-funded, but it's bifurcated: real money is going to (1) error-correction milestones and (2) revenue-adjacent "quantum-ready" software/services, while the weakest balance sheets will feel the cost of capital if rates stay sticky. Commercial timelines are "narrow use-cases first" (optimization/sensing/secure comms) before broad compute, so I treat most pure-plays as long-duration options inside a disciplined plan. Tariff wars matter less for the science and more for the bill of materials and customer procurement cycles: dilution risk rises when hardware lead times stretch, specialized components get export-controlled, or enterprise pilots freeze budgets. The China angle increases regulatory/contracting friction and supply-chain uncertainty, so I prefer companies with diversified manufacturing, non-sensitive end markets, and enough cash runway to survive a 12-24 month capex hiccup. Stocks I like right now: **IBM** (most credible "convert R&D into enterprise contracts" machine plus sticky relationships; it's a steadier way to own quantum without betting the firm) and **IonQ** (higher risk/higher upside pure-play with clearer narrative to commercialization, but I size it small and expect volatility). If a client wants one position that won't torpedo their plan in a bad month, I tilt IBM; if they want asymmetric upside and can stomach drawdowns, I'll consider IonQ as a satellite. ETF: **Defiance Quantum ETF (QTUM)**--not because it's a perfect "quantum pure-play," but because it spreads the bet across the ecosystem and helps avoid single-name blowups, which is huge for new investors. Advice: cap your allocation (I often see 1-5% as a "curiosity sleeve" depending on the plan), rebalance on a schedule, and don't average down blindly--if tariffs/liquidity shocks hit like March 2025, you want rules, not vibes.
I built competitive-intel frameworks at Northrop Grumman and now run Technology Aloha, so I look at quantum like a market-positioning problem: the "timeline" is less about a magic QPU date and more about who can turn R&D into repeatable customer value. Funding is still there, but the commercialization path is uneven--software/tooling, error mitigation, and services that attach to existing HPC/cloud budgets tend to hit revenue earlier than pure hardware bets. Tariff wars matter most where BOM + specialized components + cross-border manufacturing are hard to substitute; I'd model it like any supply-chain fragility: concentration risk, export-control risk, and "single-source vendor" risk. Companies with geographically diversified suppliers and the ability to ship value digitally (software, services, IP licensing) are less exposed than firms that must move delicate hardware across borders or depend on China-linked manufacturing capacity. Stocks I like: IBM (because they've already packaged adoption into enterprise buying motions--roadmaps, ecosystem, and procurement-friendly services) and Honeywell (because the exposure via Quantinuum gives you a serious quantum angle alongside a real industrial cash-flow base). In my agency work, I've watched "trust + distribution" beat "best tech" repeatedly--same dynamic applies when CIOs pick experimental compute partners. ETFs: Defiance Quantum ETF (QTUM) for broad "enablers" exposure without needing to pick a single winner, and ARKQ (Autonomous Tech & Robotics) if you want a more thematic basket that can benefit from adjacent compute/automation trends even if quantum timelines slip. New-investor advice: cap position sizes like you would any pre-profit tech theme, don't average down blindly, and track 3 KPIs quarterly--commercial contracts, backlog/partner traction, and gross margin direction (because "science progress" doesn't pay shareholders unless pricing power shows up).
I see quantum computing as the inevitable successor to classical silicon, but the current market is fraught with 'qubit vanity metrics.' At TAOAPEX, my approach focuses on the shift from laboratory proofs to scalable, error-corrected architectures. While pure-play companies like IonQ offer high-beta potential, the real value lies in the 'full-stack' ecosystem. I recommend investors look past the hype of raw qubit counts and prioritize companies mastering modularity and integration. IBM remains a foundational hedge due to its enterprise reach, but the mid-cap space is where the next breakthroughs in logical qubits will happen. This isn't a trade for next quarter; it's a decade-long play on the fundamental laws of physics. Position small, stay patient, and focus on the 'plumbing' of the quantum stack. In the quantum race, don't bet on the fastest sprinter; bet on the one building the track.
Quantum computing is moving fast, but we are years away from seeing real profits, even with all the cash flowing in. Honestly, ETFs like the Global X Quantum ETF are the best way to play this right now because picking individual winners is too risky. If you want to try it, start small. Look for big tech companies actually putting quantum hardware to work in things like cloud infrastructure rather than just talking about it. If you have any questions, feel free to reach out to my personal email
Quantum computing is getting the usual mix of real money and crazy hype. The actual products are still pretty messy, so I watch the backend instead. Supply chains are a headache right now, especially with tariffs hitting anyone tied to China. That is why I stick with the big tech giants. They already have the hardware and software locked down, so they will not get wrecked by trade wars. If you have any questions, feel free to reach out to my personal email
Quantum computing, although still in the early stages of commercialisation, has received financial endorsement sufficient to support its policies and product development. Investment is still supporting these technologies, as roadmaps are being defined consistently, and initial revenue opportunities are occurring in the areas of cloud access, government contracts, simulation, and optimising operations. Thus, quantum technology is moving away from the laboratory environment and will be introduced into the commercial sector in stages. As most quantum computing companies rely upon a limited number of specialised chips, hardware components and outsourcing supply chains (especially with respect to China), the quantum computing sector will remain subject to the tariff pressure and other ongoing risks associated with the global supply chain. Companies that have active quantum computing divisions and have a reasonable base of business in other sectors (e.g., IBM, Alphabet, and Microsoft) represent a safer way to protect against the impact of the quantum computing sector on their overall share price; therefore, this exposure may generate upside potential in quantum computing without the need for quantum computing to be the sole performance case for the company's stock. Conversely, companies with dedicated quantum computing business models (i.e., IonQ, Rigetti, and D-Wave) have greater upside potential than these large-cap companies, but the higher volatility impacts the share price and vice versa. For instance, for an individual investor, the use of an exchange-traded fund (ETF) such as QTUM provides greater exposure to quantum computing than owning shares of any one of these companies, thereby reducing the risk of owning an individual stock (as opposed to a larger-cap company), while still allowing for greater return potential.
Investors should expect actual commercial progress rather than just technological announcements in their investing in QCs now that funding is still robust but it is clear from what I am seeing that large companies are integrating quantum systems into their existing cloud and high-performance computing platforms. There are indications that QCs are becoming less about R&D/experimental technologies and more about commercializing them through the practical use of quantum technologies. There exist both risks and opportunities for companies involved with quantum scaffolding due to the potential risks posed by the current global trade tensions and tariffs on most manufacturers and foundries that rely heavily upon hardware supply chains. Of significant importance are companies who have substantial exposure to manufacture facilities, either located in China, or semiconductor components utilized in products manufactured there. When looking for QCs, I would encourage you to consider at least two distinct categories of investments: established technology companies and pure-play quantum companies. An example of a well-known, large-cap technology company would be IBM due to IBM's ability to execute at scale across multiple markets with established customers and long-term roadmaps. Alternatively, if you want to take on more risk with potentially higher returns you could consider investing in pure-play quantum companies such as IonQ or D-Wave Systems which have far less history than IBM but offer more direct exposure and potential upside. There are also ETFs available for both QCs and companies in related areas such as QTUM which provides an excellent way to combine multiple companies across these markets into one diversified investment. For new investors, I would suggest starting with a small allocation to either equity or ETF as a means of separating the realistic performance metrics (customer growth, bookings, product development, etc.) from the media hype surrounding these new technologies.
When I look at the quantum computing market right now, I see it as similar to where recycling tech was years ago—well-funded but still working through real-world scalability, with big players steadily pushing toward commercial use even if timelines slip. From what I've seen helping customers plan projects with long timelines, industries that require heavy infrastructure don't move fast, but they do move consistently when the money stays in, and quantum still has that backing. On tariff wars, I think the space is somewhat vulnerable—especially companies tied to China—because supply chains and specialized components can get disrupted quickly, much like I've seen delays in waste equipment sourcing when trade tensions rise. The quantum computing stocks I like right now are the ones tied to broader, stable businesses—companies like IBM or Alphabet—because they can absorb setbacks while continuing to invest, similar to how diversified contractors stay afloat during slow seasons. For ETFs, I lean toward broader tech or innovation-focused funds that include quantum exposure rather than pure-play bets, since that spreads risk in a still-developing market. If you're new and asking how to enter quantum investing, I'd treat it like choosing the right dumpster size—don't overcommit upfront; start small, diversify, and scale as you better understand your needs. I've seen too many people go all-in on one solution and regret it, and investing in emerging tech works the same way—patience and balance win.
Although the rapid rise of the quantum computing market globally continues to be heavily financed, the pace of where investments will ultimately be made has become more exclusively dependent upon the use and viability of that particular investment. Additionally, while there has been substantial advancement in overall delivery times, and while there are currently several quantum start-ups that are in some way "commercially available" - it will likely take a considerable amount of time before a large number of fault-tolerant quantum systems will be delivered to broader applications like transportation and communications. Moreover, the market's continued growth is also affected by tariffs (particularly in relation to China), export restrictions and supply chain issues, particularly involving companies with long-standing relationships to manufacturing ecosystems of sensitive semiconductors. Currently, there are two distinct and compelling categories of quantum computing companies. First, there are established start-up companies that are "pure-play" in terms of their core business model (such as IonQ or Dwave). Next, are established, larger technological companies (such as IBM and Google) that project a strong degree of certainty with regard to their respective quantum computing business models. QTUM is probably the most direct and thematic ETF available, while other, broader ETFs that invest primarily in semiconductor and infrastructure stocks also represent good investment entry points for new quantum-related investors. As such, the best advice to new investors is to stay disciplined, have exposure with a low percentage of their portfolio as possible, and not to react emotionally to the headlines - but rather focus on the qualitative elements of revenue production, accessible cash availability, and actual client demand when making investment decisions.
The quantum computing (QC) market is in a crucial R&D phase, well-funded by governments and private capital, but commercial applications are still 5-10 years out for widespread impact. It's a long-term play, not short-term. Yes, the market is vulnerable to tariff wars, especially companies reliant on global supply chains for specialized components or with ties to economies like China. This emphasizes the need for geopolitical awareness. As a tech expert, I don't give stock advice. For new investors, I'd say: 1) Deeply educate yourself on the underlying science and different quantum modalities. 2) Focus on foundational enablers (hardware, software, algorithms). 3) Be prepared for volatility and a long investment horizon. Diversify broadly; don't chase hype. This is an investment in future paradigms, not immediate profits.
The Quantum Market Reality It is finally 2026 and the quantum market finally surpassed the science fair stage. Funding is not yet dried up but has gotten significantly pickier. This means investors are not just dumping buckets of money at each startup that produces a white paper, they want logical error correction and stable qubit counts. We are officially entering the Engineering Era as the timelines to commercial drug discovery and material science application are actually not changing as much as it used to since the infrastructure around the hybrid quantum and classical computing is now functional. Geopolitical Friction and Supply Chains The biggest headwind is tariffs and trade wars. Quantum tech is a new atomic race so the geopolitical friction is immense. Any company that is highly dependent on Chinese supply chains or has exposure to revenue from that region faces a massive valuation discount. It isn't about trade it is about national security. If a company cannot demonstrate a localized or allied nation supply chain for their cryogenics or laser tech then they are an operational liability. Key Players and Architectures IBM and IonQ are prime examples. IBM is the blue chip play because they have the deepest stack and most transparent roadmap for their Heron processors. They have the capital to outlast the cycle. IonQ is a much riskier play but their trapped ion approach is scalable to room temperature much better than superconducting loops, making their hardware much better suited for data center deployment. Investment Strategy I actually like Defiance Quantum ETF. A broader play that does not just bet on hardware manufacturers, and takes in the entire ecosystem including classical semiconductor companies and particularized cooling companies that actually enable the quantum machine to work. Don't try and hunt a Tesla like breakout. Quantum is a long tail play. My advice is to forget about the day to day swings and treat this like a five to ten year allocation. If you cannot deal with the fact that these companies are not likely to show a GAAP profit in another three years, then you do not belong in this business. It is about the patents and the partnerships with big pharma or aerospace that make the real calls on who will own here.
Now we are living in a "Quantum Spring". After three years of hype, which is over for everybody but those who were in it, the market has calmed down into sensible growth. Funding continues, there are no more "tourist capitals" about, and what has stayed behind is really institutional investor who understands the tech. We see actual pilot programmes in cryptography and logistics. It is no longer a "maybe" for the commercial timeline, "when" is now a "when" and that "when" is every three months with fault tolerant systems now as the baseline. The vulnerability to Chinese tariffs is real and crippling for the unprepared. With the global tech stack bifurcated, you need to pick a side. Companies that are "entangled" in the Chinese economy see their multiples get pulverized by regulatory uncertainty. Investors are terrified by suddenly instituted export bans or delisting threats. In 2026 "clean" is no exposure to geopolitical flashpoints, especially in high spec hardware. So I am a fan of Honeywell, which they own through Quantinuum and Microsoft. So Honeywell is the "stealth leader". Their high fidelity hardware is consistently getting the performance benchmarks that people are missing. So the best software play is Microsoft because their Azure Quantum platform is almost like the "operating system" for the industry. They do not have to win the hardware race in order to win the market, they just have to be the portal that everyone uses to enter. An unconventional, but prudent way to play this is through Global X Data Center REITS 1and1 Digital Infrastructure ETF (VPN). Quantum machines will soon enter commercial use and will need bespoke data centers. This ETF captures the physical "real estate" and infrastructure for which quantum computing exists, giving you a floor, better than pure play hardware stocks. Do not strictly chase the "pure plays". Much of the best quantum tech is being developed within big diversified conglomerates with multiple sources of revenue. New investors need to create a "barbell" strategy: 70% invested in big tech conglomerates that own quantum divisions to protect against the downside, plus 30% in hardware start ups that represent speculative hardware upside. Quantum Resistant cybersecurity companies are a great example, they are immediate beneficiaries of the quantum threat irrespective of the quantum hardware race.
From my perspective as Partner at spectup, advising founders and investors on emerging tech, the quantum computing market today sits in a very familiar place, strong funding, real progress, but still largely pre-commercial at scale. Capital is still flowing, especially into hybrid models where quantum integrates with classical cloud systems, but timelines remain long, with meaningful commercial breakthroughs often projected closer to the end of the decade. On tariffs and geopolitics, yes, there is exposure. Quantum supply chains depend on semiconductors, advanced materials, and global research collaboration, so any escalation in trade tensions, especially involving China, can slow progress or fragment ecosystems. That said, it may also accelerate domestic investment in the US and Europe, which we are already seeing in strategic funding and acquisitions. In terms of stocks, I usually separate them into two buckets. Pure plays like IonQ, D-Wave, and Rigetti offer high upside but come with extreme volatility and are still largely unprofitable. Then you have diversified tech players like Alphabet, Microsoft, and IBM, which provide exposure to quantum alongside stable revenue from cloud and AI. Personally, I find the second group more compelling for most investors. On ETFs, products like the Defiance Quantum ETF (QTUM) or WisdomTree's quantum fund offer diversified exposure across hardware, software, and enabling technologies, which reduces single-company risk. For new investors, the biggest mistake is treating quantum like a near-term revenue story. It is not. This is a long-duration bet on future compute infrastructure, with high volatility along the way. At spectup, we often tell clients to approach quantum as a small, strategic allocation within a broader tech portfolio, not as a core holding. Niclas Schlopsna, Partner, spectup, https://spectup.com